Fibrosol Prebio is now ADVAGEN Prebio. New Name, Same Product
Contact
United States Office
ADVAGEN Pte Ltd
66 West Flagler Street,
Suite 900 – #8899,
Miami, FL 33130
Email: advagen.us@advagen.com
Singapore Office
ADVAGEN Pte Ltd
10 Ubi Crescent,
#05-43 Ubi Techpark,
Singapore 408564
Tel: (65) 6746 1066
Email: advagen@advagen.com
Malaysia / Brunei Office
ADVAGEN (Malaysia) Sdn Bhd
34-01 Jalan Molek 1/28,
Taman Molek,
81100 Johor Bahru, Malaysia
Email: advagen.my@advagen.com
Hong Kong / Macau Office
ADVAGEN (H.K.) Limited
Room 7B,
One Capital Place,
18 Luard Road,
Wan Chai,
Hong Kong
Email: advagen.hk@advagen.com
Pharmacovigilance Reporting
Pharmacovigilance has been defined by the World Health Organization as “science and activities related to discovery, evaluation, understanding and prevention of drug-related adverse events or any other drug-related problem”
Adverse event is any unfavourable and unwanted event that occurs in a patient who has been given a medicinal product. The objective of pharmacovigilance is to provide information to assess the risks and benefits associated with a particular medicinal product so as to enhance patient care and safety.
Healthcare personnel are required to report any adverse events associated with the use of medicinal products at the respective Health Authorities. Anyone who wishes to report an adverse event with the use of our medicinal products may contact our Pharmacovigilance Department at
Please feel free to get in touch with us and let us know how we can assist you